{"id":28254,"date":"2007-03-01T00:00:00","date_gmt":"2007-03-01T00:00:00","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/estudio-de-fase-ii-de-tres-niveles-de-dosis-de-activador-continuo-del-receptor-de-eritropoyetina-c-e-r-a-en-pacientes-anemicos-con-linfoma-no-hodgkin-agresivo-que-reciben-quimioterapia-combinada\/"},"modified":"2024-06-06T17:26:00","modified_gmt":"2024-06-06T17:26:00","slug":"estudio-de-fase-ii-de-tres-niveles-de-dosis-de-activador-continuo-del-receptor-de-eritropoyetina-c-e-r-a-en-pacientes-anemicos-con-linfoma-no-hodgkin-agresivo-que-reciben-quimioterapia-combinada","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/estudio-de-fase-ii-de-tres-niveles-de-dosis-de-activador-continuo-del-receptor-de-eritropoyetina-c-e-r-a-en-pacientes-anemicos-con-linfoma-no-hodgkin-agresivo-que-reciben-quimioterapia-combinada\/","title":{"rendered":"Estudio de fase II de tres niveles de dosis de activador continuo del receptor de eritropoyetina (C.E.R.A.) en pacientes an\u00e9micos con linfoma no Hodgkin agresivo que reciben quimioterapia combinada."},"content":{"rendered":"\n<p><span style=\"font-size: 8pt; font-family: Arial;\">Osterborg A, Steegmann JL, Hellmann A, Couban S, Mayer J, Eid JE. Br J Haematol. 2007 Mar;136(5):736-44.<\/span><\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Osterborg A, Steegmann JL, Hellmann A, Couban S, Mayer J, Eid JE. Br J Haematol. 2007 Mar;136(5):736-44.<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[317],"tags":[],"class_list":["post-28254","resources","type-resources","status-publish","hentry","category-aplicacion-medica"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/28254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=28254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=28254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=28254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}